A molecular profile that predicts response to platinum based chemotherapy in non-small cell lung cancer (NSCLC) patients

被引：0
|
作者：
Petty, RD
Murray, GI
Kerr, K
Nicolson, MC
Bissett, JD
Collie-Duguid, E
机构：
[1] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland
[2] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
[3] Aberdeen Royal Infirm, Dept Oncol, Aberdeen, Scotland
来源：
BRITISH JOURNAL OF CANCER | 2004年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Molecular profiling of response to platinum based therapy in non-small cell lung cancer (NSCLC) patients.
    Petty, RD
    Murray, GI
    Kerr, K
    Nicolson, MC
    Bissett, D
    Collie-Duguid, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 153S - 153S
  • [2] Molecular mechanisms of platinum (PT) based chemotherapy in non-small cell lung cancer patients (NSCLC) using microarrays
    Petty, RD
    Murray, GI
    Kerr, K
    Nicolson, MC
    Bissett, JD
    Collie-Duguid, E
    BRITISH JOURNAL OF CANCER, 2004, 91 : S14 - S14
  • [3] PROGNOSTIC IMPORTANCE OF RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Radosavljevic, D.
    Kezic, I.
    Jelic, S.
    Golubicic, I.
    ANNALS OF ONCOLOGY, 2008, 19 : 111 - 111
  • [4] Molecular profiles of predictive biomarkers for platinum-based chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
    Seyedabadi, NiloofarTaleghani
    Shoushtari, Sara YousefZadeh
    Soofi, Asma
    Arabpour, Javad
    Shams, Zinat
    Akhavan, Homa
    Hosseini-Asl, Saied
    META GENE, 2022, 31
  • [5] Early response to platinum-based chemotherapy in non small cell lung cancer (NSCLC) predicts survival.
    Sirohi, B
    Matakidou, A
    Ashley, S
    Popat, S
    Saka, W
    Priest, K
    Norton, A
    James, M
    Benepal, T
    Eisen, T
    O'Brien, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 672S - 672S
  • [6] Is the platinum-based chemotherapy necessary for elderly patients with advanced non-small cell lung cancer (NSCLC)?
    Daga, H.
    Takeda, K.
    Kiyota, H.
    Tokunaga, S.
    Nanjo, S.
    Sumitani, M.
    Shoji, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
    Borges, M
    Sculier, JP
    Paesmans, M
    Richez, M
    Bureau, G
    Dabouis, G
    Lecomte, J
    Michel, J
    VanCutsem, O
    Schmerber, J
    Giner, V
    Berchier, MC
    Sergysels, R
    Mommen, P
    Klastersky, J
    LUNG CANCER, 1996, 16 (01) : 21 - 33
  • [8] Early response to platinum-based chemotherapy in non small cell lung cancer (NSCLC) predicts survival unluike in mesotheliomas
    Sirohi, B
    Matakidou, A
    Benson, C
    Ashley, S
    Priest, K
    Norton, A
    James, M
    Saka, W
    Popat, S
    O'Brien, M
    LUNG CANCER, 2005, 49 : S91 - S91
  • [9] Prognostic model in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
    Radosavljevic, D. Z.
    Gavrilovic, D.
    Golubicic, I.
    Jelic, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (07): : 1035 - 1038
12345